Even when late-stage data look strong, the FDA still reviews efficacy, adverse events, manufacturing, labeling, contraindications, drug interactions, and risk-management requirements
GLP-1 is particularly relevant in conditions such as type 2 diabetes and obesity, both of which are associated with impaired glucose regulation
Safe use during pregnancy and breastfeeding is generally accepted, but only under medical supervision
Respiratory diseases can get worse, such as chronic lung illness
Yes, free sample can be provided, but shipping cost is covered by your side